articleTop 10% cited
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients
The Laryngoscope · 1998 · Vol. 108(10) · pp. 1435–1441
Andrew Blitzer✉(New York University)Mitchell F. Brin(New York University)Celia Stewart(New York University)
Abstract
Botulinum toxin A injection of the laryngeal hyperfunctional muscles has been found over the past 12 years to be the treatment of choice to control the dystonic symptoms in most patients with spasmodic dysphonia.
Voice and Speech DisordersBotulinum Toxin and Related Neurological DisordersNeurological disorders and treatmentsSpasmodic dysphoniaBotulinum toxinMedicineDystoniaAdductor musclesElectromyographyLarynxAnesthesiaFocal dystoniaPhonation
MeSH terms
AdultElectromyographyFemaleHumansMaleNeuromuscular AgentsRetrospective StudiesVoice DisordersTreatment OutcomeBotulinum Toxins, Type A
Citations
384
FWCI
4.41
field-weighted impact
References
34
Percentile
95%
vs. same field & year
Citations per year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.